Infantile Tremor Syndrome

1. Introduction and Definition

2. Epidemiology

3. Etiopathogenesis

4. Clinical Features

The disease typically evolves in stages:

A. Prodromal Phase (Pre-Tremor)

B. Tremor Phase

C. Cutaneous Changes (Hallmark)

5. Investigations

Investigation Findings
Complete Blood Count Macrocytic Anemia (MCV > 100 fL).
Pancytopenia (Leukopenia, Thrombocytopenia).
Peripheral Smear Megaloblastic picture: Macro-ovalocytes, hypersegmented neutrophils, Cabot rings, Howell-Jolly bodies.
Biochemistry Serum B12: Low (< 200 pg/mL).
Serum Folate: Normal or elevated (Folate trap).
Homocysteine & Methylmalonic Acid: Elevated.
Bone Marrow Megaloblastic hyperplasia (Erythroid:Myeloid reversal). Giant Metamyelocytes.
Neuroimaging (CT/MRI) Cerebral Atrophy: Frontoparietal widening of sulci and ventricular dilatation (ex-vacuo).
Delayed myelination.
Reversible with treatment.

6. Differential Diagnosis

Condition Differentiating Features
Viral Encephalitis Acute febrile onset, altered sensorium, CSF pleocytosis, no skin changes.
Cerebral Palsy History of birth asphyxia, spasticity (usually), non-progressive, no pigmentation.
Degenerative Brain Disease Progressive loss of milestones, no anemia/pigmentation, MRI shows specific patterns (e.g., Leukodystrophy).
Kwashiorkor Edema is prominent, tremors are rare/absent, hepatomegaly with fatty liver (rare in ITS).

7. Management

A. Specific Therapy (Vitamin B12)

B. Symptomatic Treatment for Tremors

C. Nutritional Rehabilitation

8. Prognosis